Key result
Screening first-degree relatives for unruptured intracranial aneurysms is not advised due to low rupture risk.
Why the study?
Screening for unruptured intracranial aneurysms is effective for first-degree relatives of patients with aneurysmal subarachnoid hemorrhage, but whether it is also effective for relatives of patients with unruptured intracranial aneurysms is unknown.
Does screening for UIA with MRA identify high-risk aneurysms and affect quality of life in first-degree relatives of patients with UIA?
Cohort
Yes
Does screening for UIA with MRA identify high-risk aneurysms and affect quality of life in first-degree relatives of patients with UIA?
Screening first-degree relatives of patients with unruptured intracranial aneurysms is not advised as identified aneurysms have low rupture risk, though screening does not negatively impact quality of life.
Answers are grounded in this paper and cite their sources.
Does not support routine screening of first-degree relatives; leaves open whether refined models improve risk stratification.
BACKGROUND AND OBJECTIVES: Screening for unruptured intracranial aneurysms (UIAs) is effective for first-degree relatives (FDRs) of patients with aneurysmal subarachnoid hemorrhage (aSAH). Whether screening is also effective for FDRs of patients with UIA is unknown. We determined the yield of screening in such FDRs, assessed rupture risk and treatment decisions of aneurysms that were found, identified potential high-risk subgroups, and studied the effects of screening on quality of life (QoL). METHODS: In this prospective cohort study, we included FDRs, aged 20-70 years, of patients with UIA without a family history of aSAH who visited the Neurology outpatient clinic in 1 of 3 participating tertiary referral centers in the Netherlands. FDRs were screened for UIA with magnetic resonance angiography between 2017 and 2021. We determined UIA prevalence and developed a prediction model for UIA risk at screening using multivariable logistic regression. QoL was evaluated with questionnaires 6 times during the first year after screening and assessed with a linear mixed-effects model. At all survey moments, health-related QoL and emotional functioning were comparable with those in a reference group from the general population. One FDR with a positive screening result expressed regret about screening. DISCUSSION: Based on the current data, we do not advise screening FDRs of patients with UIA because all identified UIAs had a low rupture risk. We observed no negative effect of screening on QoL. A longer follow-up should determine the risk of aneurysm growth requiring preventive treatment.
No takes yet. Share an insight, caveat, or question.
Mensing et al. (2023) conducted a cohort in Unruptured intracranial aneurysms. Magnetic resonance angiography screening vs. General population reference group was evaluated on UIA prevalence, UIA risk at screening, and quality of life (statistic 0.76, 95% CI 0.65-0.88). Screening first-degree relatives of patients with unruptured intracranial aneurysms is not advised due to low rupture risk, despite a risk prediction model yielding a statistic of 0.76.
Synapse has enriched 10 related papers. Consider them for comparative context: